Neuropeptide and melanocortin

Short peptides studied for signalling in the central nervous system. The group covers two analogs sharing a common stabilising extension that slows enzymatic breakdown, a sleep-associated peptide isolated from cerebral venous blood in the 1970s, and a melanocortin receptor agonist studied for central rather than vascular pathways.

4 compounds in this category

PRM-010 · Focus & Cognition≥ 99.0%

Semax

10mg · lyophilized

ACTH fragment analog. Studied for BDNF expression and attention.

Heptapeptide ACTH(4-10) analogue investigated for BDNF expression and cognitive performance under load.

Per vial

₱1,700₱1,890

−10%

PRM-011 · Calm & Focus≥ 99.0%

Selank

10mg · lyophilized

Tuftsin analog. Studied for anxiolytic signalling without sedation.

Tuftsin analogue heptapeptide studied for GABAergic and monoamine modulation in anxiety models.

Per vial

₱1,520₱1,690

−10%

PRM-014 · Melanocortin Pathway≥ 99.0%

PT-141

10mg · lyophilized

Melanocortin receptor agonist. Studied for central rather than vascular pathways.

Cyclic melanocortin receptor agonist investigated for MC3R and MC4R mediated pathways.

Per vial

₱1,790₱1,990

−10%

PRM-015 · Sleep & Recovery≥ 99.0%

DSIP

5mg · lyophilized

Delta sleep-inducing peptide. Studied for slow-wave sleep architecture.

Nonapeptide investigated for slow wave sleep architecture and hypothalamic signalling.

Per vial

₱980₱1,090

−10%

Sets drawing from this category

3 vials

Rest Set

Two peptides whose published work touches circadian and sleep-associated signalling, plus the diluent.

₱3,630 3 vials

Cognitive Set

The two analogs that share a stabilising extension, studied for different central nervous system endpoints.

₱3,830

Deeper reading

Compound background, published research and Philippine sourcing context sit on our partner content site. The store stays a store.

Compound library